Cboe UK CHF

Alcon Inc. (ALCZ.XC)

Compare
75.66 -0.94 (-1.23%)
At close: 4:19:51 PM GMT
Loading Chart for ALCZ.XC
DELL
  • Previous Close 76.60
  • Open 76.26
  • Bid 75.66 x --
  • Ask 75.70 x --
  • Day's Range 75.52 - 76.84
  • 52 Week Range 62.36 - 85.30
  • Volume 220,336
  • Avg. Volume 154,788
  • Market Cap (intraday) 37.421B
  • Beta (5Y Monthly) 0.73
  • PE Ratio (TTM) 36.20
  • EPS (TTM) 2.09
  • Earnings Date --
  • Forward Dividend & Yield 0.24 (0.31%)
  • Ex-Dividend Date May 14, 2024
  • 1y Target Est --

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

www.alcon.com

25,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ALCZ.XC

View More

Performance Overview: ALCZ.XC

Trailing total returns as of 12/19/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ALCZ.XC
15.71%
MSCI WORLD
17.34%

1-Year Return

ALCZ.XC
16.06%
MSCI WORLD
18.75%

3-Year Return

ALCZ.XC
26.76%
MSCI WORLD
18.44%

5-Year Return

ALCZ.XC
26.76%
MSCI WORLD
59.37%

Compare To: ALCZ.XC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ALCZ.XC

View More

Valuation Measures

Annual
As of 12/18/2024
  • Market Cap

    37.90B

  • Enterprise Value

    41.21B

  • Trailing P/E

    36.67

  • Forward P/E

    25.25

  • PEG Ratio (5yr expected)

    3.12

  • Price/Sales (ttm)

    4.37

  • Price/Book (mrq)

    2.31

  • Enterprise Value/Revenue

    4.73

  • Enterprise Value/EBITDA

    36.47

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    11.89%

  • Return on Assets (ttm)

    2.55%

  • Return on Equity (ttm)

    5.59%

  • Revenue (ttm)

    9.76B

  • Net Income Avi to Common (ttm)

    1.16B

  • Diluted EPS (ttm)

    2.09

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.99B

  • Total Debt/Equity (mrq)

    23.96%

  • Levered Free Cash Flow (ttm)

    1.31B

Research Analysis: ALCZ.XC

View More

Company Insights: ALCZ.XC

Research Reports: ALCZ.XC

View More

People Also Watch